No Prescription |
 |
 | ||
|
Amoxi Apo Amoxil |
|
| ||
No Prescription » Prescription Drugs 1 » Amoxi Apo Amoxil Amoxicillin belongs to a group of antibiotics called penicillins. It is used to treat infections caused by bacteria. The injection is used to treat more serious infections or in cases where the medicine can't be taken by mouth. Amoxicillin works by interfering with the ability of bacteria to form cell walls. The cell walls of bacteria are vital for their survival. They keep unwanted substances from entering their cells and stop the contents of their cells from leaking out. Amoxicillin impairs the bonds that hold the bacterial cell wall together. This allows holes to appear in the cell walls and kills the bacteria. Amoxicillin is a broad-spectrum antibiotic that kills a wide variety of bacteria that cause a wide variety of commonly-occuring infections. Amoxicillin may be used to treat infections of the upper or lower airways skin or soft tissue or ears. It may also be used to treat urine infections certain sexually-transmitted infections dental infections and infections affecting the blood or internal organs. To make sure the bacteria causing an infection are susceptible to amoxicillin your doctor may take a tissue sample for example a swab from the throat or skin or a urine or blood sample.What is it used for?Bacterial infections of the lungs (chest or lower respiratory tract) eg acute and chronic bronchitis pneumonia. Bacterial infection of the nasal passages sinuses or throat (upper respiratory tract infection) eg sinusitis pharyngitis laryngitis tonsillitis. Bacterial infections of the middle ear (otitis media).Bacterial infections of the urinary tract or kidneys (pyelonephritis).Bacterial infections of skin or soft tissue eg boils abscesses cellulitis impetigo.Gynaecological bacterial infections including those following childbirth or abortion.Gonorrhoea.Abdominal bacterial infections (peritonitis).Bacterial infections of the blood (septicaemia or blood poisoning).Bacterial infection of the heart valves and the lining surrounding the heart (bacterial endocarditis).Preventing infection of the heart (bacterial endocarditis) during medical or dental procedures in people with heart valve defects or artificial heart valves.Dental abscess (as addition to surgical management).Typhoid and paratyphoid fever.Lyme disease (unlicensed use).Eradicating Helicobacteria pylori bacteria in the gut that are associated with causing peptic ulcers (in combination with other medicines). Buy Amoxi Apo Amoxil and other Prescription Drugs 1 products online at Medstore. Buy Online at Medstore - Click Here!
About Amoxi Apo Amoxil: Product Type: Prescription Drugs 1 Amoxi Apo ( Amoxil Dispermox Generic Amoxicillin ) Amoxi Apo (Amoxil Dispermox Generic Amoxicillin) Amoxil Dispermox Generic Amoxicillin 250mg 500 Capsules 250mg 2 x 500 Capsules 250mg 4 x 500 Capsules 500mg 4 x 500 Capsules 500mg 500 Capsules 500mg 2 x 500 Capsules Amoxil Dispermox Generic Amoxicillin Amoxi Apo
View more Prescription Drugs 1 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
